How ordering practices impact insurance coverage with Marissa Russell, MS, LGC and Gregory Nogle

• By attending this session, you will enhance your knowledge of the genetic testing ecosystem and its impact on patient care. Come learn actionable strategies to boost patient access and navigate complex medical policies. See the latest data and insights on genetic testing ordering patterns. Learn how these trends drive changes in medical policy and directly affect patients' ability to utilize their health plan benefits. Understand the ripple effect of ordering decisions on coverage, cost, and timely care. Get real-world guidance on minimizing administrative hurdles during the genetic testing process. Additionally, we will illustrate proven approaches clinicians can adopt to simplify workflows, improve documentation, and ensure patients receive the right test at the right time. Don’t miss this opportunity to explore the future of genetic testing and unlock new pathways to patient-centered care.
  
  Level of Instruction: Intermediate

  

  Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

  

  Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Marissa Russell, MS, LGC | Presenter

Medical Policy Director, Market Access

Marissa Russell is the Medical Policy Director in the Market Access Department at Ambry Genetics. She is a licensed, board certified genetic counselor with extensive experience across clinical, health plan, and industry settings. Leveraging her deep expertise, Marissa partners collaboratively to align medical policy and optimize patient access to genetic testing. A dedicated patient advocate, she is focused on reducing barriers so that appropriate patients receive the right genetic test at the right time and cost.

Gregory Nogle | Presenter

Vice President, Market Access

Greg Nogle has had an extensive history within the market access field and is currently the vice President of Market Access for Ambry Genetics, a Tempus company. In this role, he is responsible for leading the team in integrating coverage initiatives with CMS/Medicare contractors and driving reimbursement strategies for commercial and government payers. In addition, he directs coverage efforts aligned with internal and external clinical stakeholders to drive policy changes within molecular diagnostics. In his career, Greg held positions on the payor side, creating clinical and ancillary networks under risk and alternative payment models. He holds a B.S. from LSU where he focused on economics and history.

Connolly Steigerwald, MS, CGC | Moderator

Genomic Science Liaison

Connolly Steigerwald MS, CGC is a Genomic Science Liaison at Ambry Genetics. She is certified by the American Board of Genetic Counseling and earned her MS in Genetic Counseling from Columbia University in New York City. She previously worked as a clinical genetic counselor within the Lysosomal Storage Disorders Program and Division of Neurogenetics at NYU Langone Health. Her clinical and research interests have spanned lysosomal storage disorders, adult-onset neurodegenerative disease, and predictive genetic testing. She is an active member of the New York State Genetics Task Force Education Committee.